Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. [electronic resource]
Producer: 20020830Description: 435-41 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Benzamides
- Blood Cells -- cytology
- Bone Marrow Cells -- cytology
- Cytogenetic Analysis
- Drug Resistance
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl -- analysis
- Humans
- Imatinib Mesylate
- Interferon-alpha -- administration & dosage
- Karyotyping
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Philadelphia Chromosome
- Piperazines -- administration & dosage
- Pyrimidines -- administration & dosage
- Remission Induction -- methods
- Retrospective Studies
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.